Skin Immunity Sample Collection Involving Blisters and Biopsies
Key facts
- Who runs it
- National Institute of Allergy and Infectious Diseases (NIAID)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Phase
- Early phase 1
- Started
- 9 Dec 2024
- Ended
- 10 Dec 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Blister induction
- Skin Biopsies
- Record updated
- 13 December 2024
- Why it stopped
- Study closed by PI, no enrollment.
Who can take part
- Age
- 7 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (7)Hide the full registry criteria
Who cannot take part
- Current or prior (within 3 months) use of immunomodulatory drugs (e.g., chemotherapy, steroids), except if approved by the principal investigator
- For individuals undergoing blister or skin biopsy procedures, history of keloid formation
- Any condition that, in the opinion of the investigator, contraindicates participation in the study
- Current or prior (within 3 months) anticoagulant or anti-platelet therapy (other than aspirin or non-steroidal anti-inflammatory drugs [NSAIDs])
- The following exclusion criteria apply to all subjects:
- Pregnancy
Other criteria
- INCLUSION CRITERIA:; Meets one of the following:; has documentation of HIES or CGD (patient populations); or; does not have clinically apparent evidence of an immune defect or history of invasive or recurrent S. aureus infections (healthy volunteers); Between the following age limits (inclusive):; 18 and 65 years old for healthy volunteers; 7 and 65 years old for patients with CGD; 18 and 65 years old for patients with HIES; Willing to allow storage of blood, RNA, bacterial and fungal cultures, and other tissue samples for future research; Able to provide informed consent
Where in United States
- National Institutes of Health Clinical CenterBethesda, United States
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
The way the body heals and protects itself from getting sick is called the immune response. Some people with weak immune systems get sick often or get rashes and skin infections. Researchers want to find out how the immune system and skin problems are related so they can help these people.
Objective:
To learn about how immune response and skin healing are related to each other.
Eligibility:
People ages 18-65 with hyper IgE syndrome or Job syndrome or people ages 7-65 with chronic granulomatous disease. Healthy volunteers ages 18 65 are also needed.
Design:
Participants will be screened with:
Medical history
Physical exam
Possible urine tests
Participants will have 1 to 3 visits within about a week. Visits will include the following:
Participants will have a wells device strapped to the inside of the forearm. It will suction the skin and pull the top layer away to form 8 blisters. The skin over the blisters and the liquid inside will be collected.
Participants will have up to 4 skin biopsies. A sharp tool will remove a small plug of skin from the forearm.
Participants may have blood and urine tests.
The skin on participants skin will be rubbed with a cotton swab.
Some participants will have an overnight visit. They will have the blister device placed back on the arm. The wells will be lined up over the blister wounds. The wells will be filled with either saline or the participant s blood serum. The device will be covered and left on the arm for up to 24 hours. Doctors will periodically remove some liquid from the wells.
The 2 groups in the trial
- 1Other group
Blister Induction
Treatment: Blister induction
- 2Other group
Skin Biopsies
Treatment: Skin Biopsies
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 13 December 2024